{"gene":"SLX4IP","run_date":"2026-06-10T07:46:35","timeline":{"discoveries":[{"year":2019,"finding":"SLX4IP accumulates at ALT telomeres and physically interacts with SLX4, XPF, and BLM, antagonizing promiscuous BLM (BTR complex) activity to favor SMX-dependent resolution during ALT recombination. Loss of SLX4IP increases ALT-related phenotypes, and concomitant loss of SLX4 causes synthetic lethality that is rescued by BLM inactivation, placing SLX4IP as a regulator that balances SMX resolution versus BTR dissolution at recombining telomeres.","method":"Co-immunoprecipitation, genetic epistasis (double-mutant rescue by BLM loss), loss-of-function with telomere phenotype readouts, live-cell localization","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal interactions confirmed, genetic epistasis with double-mutant rescue, multiple orthogonal methods, independently consistent with parallel studies","pmids":["31447390"],"is_preprint":false},{"year":2019,"finding":"SLX4IP binds simultaneously to SLX4 and XPF-ERCC1 and is required to maintain the stability of the SLX4-XPF-ERCC1 complex, especially after DNA damage. Disruption of either binding interface (SLX4 or XPF-ERCC1) also disrupts the other interaction and destabilizes SLX4IP protein. SLX4IP depletion sensitizes cells to ICL-inducing agents and causes G2/M accumulation.","method":"Co-immunoprecipitation, depletion experiments with ICL sensitivity assay, cell cycle analysis","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP with domain disruption, cell-viability and cell-cycle readouts, multiple orthogonal methods in single lab","pmids":["31495888"],"is_preprint":false},{"year":2021,"finding":"SLX4IP recruits and activates the E3 SUMO ligase PIAS1 to the SLX4 complex, leading to PIAS1-mediated SUMOylation of the telomere-binding protein RAP1. SUMOylated RAP1 dissociates from TRF2 and shuttles to the cytosol where it binds IKK, activating NF-κB and inducing Jagged-1 expression, which promotes Notch signaling and institution of ALT.","method":"Co-immunoprecipitation, proteomics/mass spectrometry (telomere proteome composition), SUMOylation assay, subcellular fractionation, signaling pathway analysis","journal":"Science signaling","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP and SUMOylation assays, mass spectrometry for proteome, single lab with multiple orthogonal methods","pmids":["34187905"],"is_preprint":false},{"year":2020,"finding":"SLX4IP inactivation in breast cancer cells suppresses ALT and coincides with activation of telomerase, demonstrating that SLX4IP regulates the choice between telomere maintenance mechanisms (TMMs). Pharmacologic and genetic modulation of TMMs downstream of SLX4IP elicits telomere-dependent cell death.","method":"Genetic screen, loss-of-function (SLX4IP inactivation), ALT and telomerase activity assays","journal":"Life science alliance","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic loss-of-function with defined TMM phenotypic readout, single lab with multiple assays","pmids":["32071280"],"is_preprint":false},{"year":2020,"finding":"SLX4IP overexpression in AR-dependent prostate cancer cells promotes an ALT-like phenotype and telomere maintenance; SLX4IP knockdown in AR-independent CRPC cells reduces ALT-like hallmarks, causes telomere shortening, and induces senescence. In PC-3 xenografts, SLX4IP knockdown reduced tumor volume.","method":"Overexpression, siRNA knockdown, ALT hallmark assays (APB detection by IF-FISH), telomere length measurement, xenograft model","journal":"Molecular cancer research : MCR","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gain- and loss-of-function with multiple cellular and in vivo readouts, single lab","pmids":["33188147"],"is_preprint":false},{"year":2021,"finding":"The N-terminus of SLX4IP is sufficient to direct its localization to ALT-associated PML bodies (APBs) and telomeres, and this N-terminal localization is required for SLX4IP-dependent promotion of APB formation, telomere length preservation, and rescue from senescence in AR-negative CRPC cells.","method":"Stable expression of truncation/deletion constructs with 3xFLAG tag, IF-FISH for APB/telomere colocalization, co-immunoprecipitation, telomere length assay, senescence assay","journal":"The Prostate","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — domain mapping with multiple functional readouts, single lab","pmids":["34492133"],"is_preprint":false},{"year":2025,"finding":"SLX4IP localizes to stressed common fragile sites (CFSs) and its loss exacerbates CFS expression and genome instability. Genetic epistasis between SLX4IP and FANCP/SLX4 indicates they act in the same pathway to maintain CFS stability. In zebrafish, homozygous knockout of slx4ip causes embryonic anomalies and sensitivity to DNA crosslinking agents, phenocopying Fanconi anemia.","method":"Chromatin localization assay, CFS cytogenetic analysis, genetic epistasis (double depletion), zebrafish knockout model with ICL sensitivity assay","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — epistasis and in vivo knockout with multiple orthogonal readouts, single study","pmids":["40383148"],"is_preprint":false},{"year":2026,"finding":"SLX4IP localizes broadly across chromatin and restrains BLM helicase activity genome-wide to maintain replication fork stability. Loss of SLX4IP slows replication forks, remodels the replisome, generates post-replicative ssDNA gaps, and elevates nuclear ADP ribose. At ALT telomeres, SLX4IP acts in parallel with FANCM to restrain BLM; co-depletion of SLX4IP and FANCM causes synthetic lethality in ALT-positive cells that is fully rescued by BLM loss.","method":"Genome-wide chromatin localization, replication fork assays (fiber assay), replisome proteomics, ssDNA gap detection, genetic epistasis (triple mutant rescue by BLM loss), synthetic lethality screen","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods including genome-wide localization, fork assays, epistasis with triple-mutant rescue, consistent with parallel preprint findings","pmids":["42098304"],"is_preprint":false},{"year":2025,"finding":"SLX4IP suppresses BLM-driven replication stress specifically on the lagging strand at ALT telomeres by limiting unwinding of unligated Okazaki fragments by BLM, thereby reducing toxic 5′ DNA flap formation, preventing ATR hyperactivation, and preventing deleterious recombination. SLX4IP and FANCM act in parallel to restrain BLM, and their co-depletion causes synthetic lethality rescued by BLM loss.","method":"Replication fork analysis (fiber assay), Okazaki fragment assay, ATR signaling readout, genetic epistasis with BLM and FANCM double/triple depletions, synthetic lethality assay in ALT cells","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple mechanistic assays and epistasis in single preprint lab, results consistent with published EMBO paper","pmids":["40501906"],"is_preprint":true}],"current_model":"SLX4IP is a genome-wide regulator of replication fork integrity that restrains BLM helicase activity—limiting unwinding of Okazaki fragments on the lagging strand, preventing toxic ssDNA flap formation, and suppressing ATR hyperactivation—while at ALT telomeres it coordinates with FANCM in parallel to balance BLM-driven replication stress and recombination; it also scaffolds the SLX4-XPF-ERCC1 complex for ICL repair, recruits PIAS1 to SUMOylate RAP1 (promoting NF-κB/Notch signaling and ALT), and its N-terminus directs telomeric/APB localization required for ALT maintenance."},"narrative":{"mechanistic_narrative":"SLX4IP is a genome-integrity factor that controls the balance between recombination/dissolution activities at DNA replication forks and at telomeres by restraining the BLM helicase [PMID:31447390, PMID:42098304]. Genome-wide, SLX4IP localizes broadly across chromatin and limits BLM activity to maintain replication fork stability; its loss slows forks, remodels the replisome, generates post-replicative ssDNA gaps, and elevates nuclear ADP ribose [PMID:42098304]. At ALT telomeres it physically interacts with SLX4, XPF, and BLM and antagonizes promiscuous BLM (BTR) activity to favor SMX-dependent resolution, acting in parallel with FANCM such that co-depletion of SLX4IP with either SLX4 or FANCM produces synthetic lethality that is rescued by BLM inactivation [PMID:31447390, PMID:42098304]. SLX4IP binds simultaneously to SLX4 and XPF-ERCC1 and is required for the stability of the SLX4-XPF-ERCC1 complex, and its depletion sensitizes cells to interstrand crosslink-inducing agents with G2/M accumulation [PMID:31495888]; consistent with a Fanconi-anemia-pathway role, slx4ip knockout zebrafish display embryonic anomalies and crosslinker sensitivity, and SLX4IP acts in the same pathway as FANCP/SLX4 to stabilize common fragile sites [PMID:40383148]. Beyond structure-specific endonuclease scaffolding, SLX4IP recruits the SUMO ligase PIAS1 to SUMOylate RAP1, driving its dissociation from TRF2 and cytosolic activation of NF-κB/Notch signaling to institute ALT [PMID:34187905]. SLX4IP thereby governs the choice of telomere maintenance mechanism, with its N-terminus directing localization to ALT-associated PML bodies and telomeres required for ALT maintenance [PMID:32071280, PMID:34492133].","teleology":[{"year":2019,"claim":"Established SLX4IP as a telomeric regulator that tips the balance between SMX resolution and BTR dissolution by physically engaging the SLX4 complex and antagonizing BLM.","evidence":"Co-IP, genetic epistasis with double-mutant rescue by BLM loss, and telomere phenotype readouts in ALT cells","pmids":["31447390"],"confidence":"High","gaps":["Did not define how SLX4IP biochemically inhibits BLM","Did not map the binding interfaces on SLX4 or BLM"]},{"year":2019,"claim":"Showed SLX4IP is an architectural component required for SLX4-XPF-ERCC1 complex stability and ICL repair, defining a role beyond telomeres.","evidence":"Reciprocal Co-IP with interface disruption, ICL sensitivity assays, and cell cycle analysis","pmids":["31495888"],"confidence":"High","gaps":["No structure of the SLX4IP-SLX4-XPF-ERCC1 assembly","Did not resolve whether scaffolding and BLM-restraining functions are separable"]},{"year":2020,"claim":"Demonstrated SLX4IP governs the choice between telomere maintenance mechanisms, with loss suppressing ALT and activating telomerase in a tumor-context-dependent manner.","evidence":"Genetic screen, loss- and gain-of-function with ALT/telomerase assays in breast and prostate cancer cells, and PC-3 xenografts","pmids":["32071280","33188147"],"confidence":"Medium","gaps":["Mechanism coupling SLX4IP loss to telomerase activation not defined","Context-dependence on AR status not mechanistically explained"]},{"year":2021,"claim":"Identified a signaling arm whereby SLX4IP recruits PIAS1 to SUMOylate RAP1, linking telomere protein modification to NF-κB/Notch activation and ALT induction.","evidence":"Co-IP, telomere proteomics, SUMOylation assays, subcellular fractionation, and pathway analysis","pmids":["34187905"],"confidence":"Medium","gaps":["Single-lab evidence without reciprocal validation of the RAP1-IKK axis in other models","Relationship between this signaling role and the BLM-restraining role unresolved"]},{"year":2021,"claim":"Mapped the SLX4IP N-terminus as the determinant sufficient and required for APB/telomere localization and ALT maintenance.","evidence":"Truncation/deletion constructs with IF-FISH colocalization, telomere length and senescence assays in CRPC cells","pmids":["34492133"],"confidence":"Medium","gaps":["The direct binding partner that recruits the N-terminus to APBs is not identified","Domain mapping done in a single cell context"]},{"year":2025,"claim":"Extended SLX4IP function to common fragile site stability within the Fanconi anemia pathway and validated an in vivo requirement.","evidence":"Chromatin localization, CFS cytogenetics, FANCP/SLX4 epistasis, and slx4ip knockout zebrafish with ICL sensitivity","pmids":["40383148"],"confidence":"Medium","gaps":["Whether CFS protection uses the same BLM-restraining mechanism as telomeres untested","No mammalian whole-organism model reported"]},{"year":2026,"claim":"Generalized SLX4IP into a genome-wide restraint on BLM that preserves replication fork integrity, with telomeric action functioning in parallel to FANCM.","evidence":"Genome-wide chromatin localization, fiber assays, replisome proteomics, ssDNA gap detection, and triple-mutant rescue by BLM loss","pmids":["42098304"],"confidence":"High","gaps":["Direct biochemical mechanism of BLM inhibition still not reconstituted","How elevated nuclear ADP ribose feeds back on fork outcomes unclear"]},{"year":2025,"claim":"Provided a strand-specific mechanism: SLX4IP limits BLM unwinding of unligated Okazaki fragments on the lagging strand to prevent toxic 5' flaps and ATR hyperactivation.","evidence":"Fiber and Okazaki fragment assays, ATR signaling readouts, and BLM/FANCM epistasis in ALT cells (preprint)","pmids":["40501906"],"confidence":"Medium","gaps":["Preprint; awaits peer-reviewed confirmation of the lagging-strand flap model","Direct demonstration of SLX4IP binding to Okazaki-fragment intermediates lacking"]},{"year":null,"claim":"The direct biochemical basis by which SLX4IP inhibits BLM helicase, and whether its scaffolding, SUMO-recruitment, and BLM-restraining activities are mechanistically independent, remain unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No reconstituted SLX4IP-BLM biochemistry","No structural model of SLX4IP within the SLX4 complex","Functional separability of the multiple SLX4IP activities untested"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[2]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[0,1]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,7]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[7]},{"term_id":"GO:0000228","term_label":"nuclear chromosome","supporting_discovery_ids":[0,5,6]}],"pathway":[{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[1,6]},{"term_id":"R-HSA-69306","term_label":"DNA Replication","supporting_discovery_ids":[7]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[3,4]}],"complexes":["SLX4-XPF-ERCC1 complex","SMX resolvase complex"],"partners":["SLX4","XPF","ERCC1","BLM","FANCM","PIAS1","RAP1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q5VYV7","full_name":"Protein SLX4IP","aliases":["SLX4-interacting protein"],"length_aa":408,"mass_kda":45.6,"function":"","subcellular_location":"","url":"https://www.uniprot.org/uniprotkb/Q5VYV7/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/SLX4IP","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/SLX4IP","total_profiled":1310},"omim":[{"mim_id":"615958","title":"SLX4-INTERACTING PROTEIN; SLX4IP","url":"https://www.omim.org/entry/615958"},{"mim_id":"615823","title":"SLX1 HOMOLOG B, STRUCTURE-SPECIFIC ENDONUCLEASE SUBUNIT; SLX1B","url":"https://www.omim.org/entry/615823"},{"mim_id":"615822","title":"SLX1 HOMOLOG A, STRUCTURE-SPECIFIC ENDONUCLEASE SUBUNIT; SLX1A","url":"https://www.omim.org/entry/615822"},{"mim_id":"613278","title":"SLX4 STRUCTURE-SPECIFIC ENDONUCLEASE SUBUNIT; SLX4","url":"https://www.omim.org/entry/613278"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Cytosol","reliability":"Approved"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in many","driving_tissues":[],"url":"https://www.proteinatlas.org/search/SLX4IP"},"hgnc":{"alias_symbol":["dJ1099D15.3"],"prev_symbol":["C20orf94"]},"alphafold":{"accession":"Q5VYV7","domains":[{"cath_id":"-","chopping":"3-126","consensus_level":"high","plddt":82.6431,"start":3,"end":126}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q5VYV7","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q5VYV7-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q5VYV7-F1-predicted_aligned_error_v6.png","plddt_mean":54.75},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=SLX4IP","jax_strain_url":"https://www.jax.org/strain/search?query=SLX4IP"},"sequence":{"accession":"Q5VYV7","fasta_url":"https://rest.uniprot.org/uniprotkb/Q5VYV7.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q5VYV7/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q5VYV7"}},"corpus_meta":[{"pmid":"31447390","id":"PMC_31447390","title":"SLX4IP Antagonizes Promiscuous BLM Activity during ALT Maintenance.","date":"2019","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/31447390","citation_count":76,"is_preprint":false},{"pmid":"31495888","id":"PMC_31495888","title":"SLX4IP acts with SLX4 and XPF-ERCC1 to promote interstrand crosslink repair.","date":"2019","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/31495888","citation_count":31,"is_preprint":false},{"pmid":"32071280","id":"PMC_32071280","title":"SLX4IP and telomere dynamics dictate breast cancer metastasis and therapeutic responsiveness.","date":"2020","source":"Life science alliance","url":"https://pubmed.ncbi.nlm.nih.gov/32071280","citation_count":20,"is_preprint":false},{"pmid":"34187905","id":"PMC_34187905","title":"SLX4IP promotes RAP1 SUMOylation by PIAS1 to coordinate telomere maintenance through NF-κB and Notch signaling.","date":"2021","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/34187905","citation_count":20,"is_preprint":false},{"pmid":"24045615","id":"PMC_24045615","title":"Frequent and sex-biased deletion of SLX4IP by illegitimate V(D)J-mediated recombination in childhood acute lymphoblastic leukemia.","date":"2013","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24045615","citation_count":15,"is_preprint":false},{"pmid":"33188147","id":"PMC_33188147","title":"SLX4IP Promotes Telomere Maintenance in Androgen Receptor-Independent Castration-Resistant Prostate Cancer through ALT-like Telomeric PML Localization.","date":"2020","source":"Molecular cancer research : MCR","url":"https://pubmed.ncbi.nlm.nih.gov/33188147","citation_count":5,"is_preprint":false},{"pmid":"40383148","id":"PMC_40383148","title":"Loss of SLX4IP leads to common fragile site instability and compromises DNA interstrand crosslink repair in vivo.","date":"2025","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/40383148","citation_count":2,"is_preprint":false},{"pmid":"40501906","id":"PMC_40501906","title":"SLX4IP acts in parallel to FANCM to limit BLM-dependent replication stress at ALT telomeres.","date":"2025","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/40501906","citation_count":0,"is_preprint":false},{"pmid":"34492133","id":"PMC_34492133","title":"SLX4IP N-terminus dictates telomeric localization in ALT-like castration-resistant prostate cancer cell lines.","date":"2021","source":"The Prostate","url":"https://pubmed.ncbi.nlm.nih.gov/34492133","citation_count":0,"is_preprint":false},{"pmid":"42098304","id":"PMC_42098304","title":"SLX4IP limits replication stress globally and at ALT telomeres.","date":"2026","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/42098304","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":7173,"output_tokens":2519,"usd":0.029652,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":9675,"output_tokens":3124,"usd":0.063238,"stage2_stop_reason":"end_turn"},"total_usd":0.09289,"stage1_batch_id":"msgbatch_013LWZZT6MWaqB9qyTSeQBmU","stage2_batch_id":"msgbatch_0194ZzQaTGNpruoNJBbEMbt3","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2019,\n      \"finding\": \"SLX4IP accumulates at ALT telomeres and physically interacts with SLX4, XPF, and BLM, antagonizing promiscuous BLM (BTR complex) activity to favor SMX-dependent resolution during ALT recombination. Loss of SLX4IP increases ALT-related phenotypes, and concomitant loss of SLX4 causes synthetic lethality that is rescued by BLM inactivation, placing SLX4IP as a regulator that balances SMX resolution versus BTR dissolution at recombining telomeres.\",\n      \"method\": \"Co-immunoprecipitation, genetic epistasis (double-mutant rescue by BLM loss), loss-of-function with telomere phenotype readouts, live-cell localization\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal interactions confirmed, genetic epistasis with double-mutant rescue, multiple orthogonal methods, independently consistent with parallel studies\",\n      \"pmids\": [\"31447390\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"SLX4IP binds simultaneously to SLX4 and XPF-ERCC1 and is required to maintain the stability of the SLX4-XPF-ERCC1 complex, especially after DNA damage. Disruption of either binding interface (SLX4 or XPF-ERCC1) also disrupts the other interaction and destabilizes SLX4IP protein. SLX4IP depletion sensitizes cells to ICL-inducing agents and causes G2/M accumulation.\",\n      \"method\": \"Co-immunoprecipitation, depletion experiments with ICL sensitivity assay, cell cycle analysis\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP with domain disruption, cell-viability and cell-cycle readouts, multiple orthogonal methods in single lab\",\n      \"pmids\": [\"31495888\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"SLX4IP recruits and activates the E3 SUMO ligase PIAS1 to the SLX4 complex, leading to PIAS1-mediated SUMOylation of the telomere-binding protein RAP1. SUMOylated RAP1 dissociates from TRF2 and shuttles to the cytosol where it binds IKK, activating NF-κB and inducing Jagged-1 expression, which promotes Notch signaling and institution of ALT.\",\n      \"method\": \"Co-immunoprecipitation, proteomics/mass spectrometry (telomere proteome composition), SUMOylation assay, subcellular fractionation, signaling pathway analysis\",\n      \"journal\": \"Science signaling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP and SUMOylation assays, mass spectrometry for proteome, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"34187905\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"SLX4IP inactivation in breast cancer cells suppresses ALT and coincides with activation of telomerase, demonstrating that SLX4IP regulates the choice between telomere maintenance mechanisms (TMMs). Pharmacologic and genetic modulation of TMMs downstream of SLX4IP elicits telomere-dependent cell death.\",\n      \"method\": \"Genetic screen, loss-of-function (SLX4IP inactivation), ALT and telomerase activity assays\",\n      \"journal\": \"Life science alliance\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic loss-of-function with defined TMM phenotypic readout, single lab with multiple assays\",\n      \"pmids\": [\"32071280\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"SLX4IP overexpression in AR-dependent prostate cancer cells promotes an ALT-like phenotype and telomere maintenance; SLX4IP knockdown in AR-independent CRPC cells reduces ALT-like hallmarks, causes telomere shortening, and induces senescence. In PC-3 xenografts, SLX4IP knockdown reduced tumor volume.\",\n      \"method\": \"Overexpression, siRNA knockdown, ALT hallmark assays (APB detection by IF-FISH), telomere length measurement, xenograft model\",\n      \"journal\": \"Molecular cancer research : MCR\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain- and loss-of-function with multiple cellular and in vivo readouts, single lab\",\n      \"pmids\": [\"33188147\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"The N-terminus of SLX4IP is sufficient to direct its localization to ALT-associated PML bodies (APBs) and telomeres, and this N-terminal localization is required for SLX4IP-dependent promotion of APB formation, telomere length preservation, and rescue from senescence in AR-negative CRPC cells.\",\n      \"method\": \"Stable expression of truncation/deletion constructs with 3xFLAG tag, IF-FISH for APB/telomere colocalization, co-immunoprecipitation, telomere length assay, senescence assay\",\n      \"journal\": \"The Prostate\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — domain mapping with multiple functional readouts, single lab\",\n      \"pmids\": [\"34492133\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"SLX4IP localizes to stressed common fragile sites (CFSs) and its loss exacerbates CFS expression and genome instability. Genetic epistasis between SLX4IP and FANCP/SLX4 indicates they act in the same pathway to maintain CFS stability. In zebrafish, homozygous knockout of slx4ip causes embryonic anomalies and sensitivity to DNA crosslinking agents, phenocopying Fanconi anemia.\",\n      \"method\": \"Chromatin localization assay, CFS cytogenetic analysis, genetic epistasis (double depletion), zebrafish knockout model with ICL sensitivity assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — epistasis and in vivo knockout with multiple orthogonal readouts, single study\",\n      \"pmids\": [\"40383148\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"SLX4IP localizes broadly across chromatin and restrains BLM helicase activity genome-wide to maintain replication fork stability. Loss of SLX4IP slows replication forks, remodels the replisome, generates post-replicative ssDNA gaps, and elevates nuclear ADP ribose. At ALT telomeres, SLX4IP acts in parallel with FANCM to restrain BLM; co-depletion of SLX4IP and FANCM causes synthetic lethality in ALT-positive cells that is fully rescued by BLM loss.\",\n      \"method\": \"Genome-wide chromatin localization, replication fork assays (fiber assay), replisome proteomics, ssDNA gap detection, genetic epistasis (triple mutant rescue by BLM loss), synthetic lethality screen\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods including genome-wide localization, fork assays, epistasis with triple-mutant rescue, consistent with parallel preprint findings\",\n      \"pmids\": [\"42098304\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"SLX4IP suppresses BLM-driven replication stress specifically on the lagging strand at ALT telomeres by limiting unwinding of unligated Okazaki fragments by BLM, thereby reducing toxic 5′ DNA flap formation, preventing ATR hyperactivation, and preventing deleterious recombination. SLX4IP and FANCM act in parallel to restrain BLM, and their co-depletion causes synthetic lethality rescued by BLM loss.\",\n      \"method\": \"Replication fork analysis (fiber assay), Okazaki fragment assay, ATR signaling readout, genetic epistasis with BLM and FANCM double/triple depletions, synthetic lethality assay in ALT cells\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple mechanistic assays and epistasis in single preprint lab, results consistent with published EMBO paper\",\n      \"pmids\": [\"40501906\"],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"SLX4IP is a genome-wide regulator of replication fork integrity that restrains BLM helicase activity—limiting unwinding of Okazaki fragments on the lagging strand, preventing toxic ssDNA flap formation, and suppressing ATR hyperactivation—while at ALT telomeres it coordinates with FANCM in parallel to balance BLM-driven replication stress and recombination; it also scaffolds the SLX4-XPF-ERCC1 complex for ICL repair, recruits PIAS1 to SUMOylate RAP1 (promoting NF-κB/Notch signaling and ALT), and its N-terminus directs telomeric/APB localization required for ALT maintenance.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"SLX4IP is a genome-integrity factor that controls the balance between recombination/dissolution activities at DNA replication forks and at telomeres by restraining the BLM helicase [#0, #7]. Genome-wide, SLX4IP localizes broadly across chromatin and limits BLM activity to maintain replication fork stability; its loss slows forks, remodels the replisome, generates post-replicative ssDNA gaps, and elevates nuclear ADP ribose [#7]. At ALT telomeres it physically interacts with SLX4, XPF, and BLM and antagonizes promiscuous BLM (BTR) activity to favor SMX-dependent resolution, acting in parallel with FANCM such that co-depletion of SLX4IP with either SLX4 or FANCM produces synthetic lethality that is rescued by BLM inactivation [#0, #7]. SLX4IP binds simultaneously to SLX4 and XPF-ERCC1 and is required for the stability of the SLX4-XPF-ERCC1 complex, and its depletion sensitizes cells to interstrand crosslink-inducing agents with G2/M accumulation [#1]; consistent with a Fanconi-anemia-pathway role, slx4ip knockout zebrafish display embryonic anomalies and crosslinker sensitivity, and SLX4IP acts in the same pathway as FANCP/SLX4 to stabilize common fragile sites [#6]. Beyond structure-specific endonuclease scaffolding, SLX4IP recruits the SUMO ligase PIAS1 to SUMOylate RAP1, driving its dissociation from TRF2 and cytosolic activation of NF-\\u03baB/Notch signaling to institute ALT [#2]. SLX4IP thereby governs the choice of telomere maintenance mechanism, with its N-terminus directing localization to ALT-associated PML bodies and telomeres required for ALT maintenance [#3, #5].\",\n  \"teleology\": [\n    {\n      \"year\": 2019,\n      \"claim\": \"Established SLX4IP as a telomeric regulator that tips the balance between SMX resolution and BTR dissolution by physically engaging the SLX4 complex and antagonizing BLM.\",\n      \"evidence\": \"Co-IP, genetic epistasis with double-mutant rescue by BLM loss, and telomere phenotype readouts in ALT cells\",\n      \"pmids\": [\"31447390\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define how SLX4IP biochemically inhibits BLM\", \"Did not map the binding interfaces on SLX4 or BLM\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Showed SLX4IP is an architectural component required for SLX4-XPF-ERCC1 complex stability and ICL repair, defining a role beyond telomeres.\",\n      \"evidence\": \"Reciprocal Co-IP with interface disruption, ICL sensitivity assays, and cell cycle analysis\",\n      \"pmids\": [\"31495888\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No structure of the SLX4IP-SLX4-XPF-ERCC1 assembly\", \"Did not resolve whether scaffolding and BLM-restraining functions are separable\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Demonstrated SLX4IP governs the choice between telomere maintenance mechanisms, with loss suppressing ALT and activating telomerase in a tumor-context-dependent manner.\",\n      \"evidence\": \"Genetic screen, loss- and gain-of-function with ALT/telomerase assays in breast and prostate cancer cells, and PC-3 xenografts\",\n      \"pmids\": [\"32071280\", \"33188147\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism coupling SLX4IP loss to telomerase activation not defined\", \"Context-dependence on AR status not mechanistically explained\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Identified a signaling arm whereby SLX4IP recruits PIAS1 to SUMOylate RAP1, linking telomere protein modification to NF-\\u03baB/Notch activation and ALT induction.\",\n      \"evidence\": \"Co-IP, telomere proteomics, SUMOylation assays, subcellular fractionation, and pathway analysis\",\n      \"pmids\": [\"34187905\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab evidence without reciprocal validation of the RAP1-IKK axis in other models\", \"Relationship between this signaling role and the BLM-restraining role unresolved\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Mapped the SLX4IP N-terminus as the determinant sufficient and required for APB/telomere localization and ALT maintenance.\",\n      \"evidence\": \"Truncation/deletion constructs with IF-FISH colocalization, telomere length and senescence assays in CRPC cells\",\n      \"pmids\": [\"34492133\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"The direct binding partner that recruits the N-terminus to APBs is not identified\", \"Domain mapping done in a single cell context\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Extended SLX4IP function to common fragile site stability within the Fanconi anemia pathway and validated an in vivo requirement.\",\n      \"evidence\": \"Chromatin localization, CFS cytogenetics, FANCP/SLX4 epistasis, and slx4ip knockout zebrafish with ICL sensitivity\",\n      \"pmids\": [\"40383148\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether CFS protection uses the same BLM-restraining mechanism as telomeres untested\", \"No mammalian whole-organism model reported\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Generalized SLX4IP into a genome-wide restraint on BLM that preserves replication fork integrity, with telomeric action functioning in parallel to FANCM.\",\n      \"evidence\": \"Genome-wide chromatin localization, fiber assays, replisome proteomics, ssDNA gap detection, and triple-mutant rescue by BLM loss\",\n      \"pmids\": [\"42098304\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct biochemical mechanism of BLM inhibition still not reconstituted\", \"How elevated nuclear ADP ribose feeds back on fork outcomes unclear\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Provided a strand-specific mechanism: SLX4IP limits BLM unwinding of unligated Okazaki fragments on the lagging strand to prevent toxic 5' flaps and ATR hyperactivation.\",\n      \"evidence\": \"Fiber and Okazaki fragment assays, ATR signaling readouts, and BLM/FANCM epistasis in ALT cells (preprint)\",\n      \"pmids\": [\"40501906\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Preprint; awaits peer-reviewed confirmation of the lagging-strand flap model\", \"Direct demonstration of SLX4IP binding to Okazaki-fragment intermediates lacking\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The direct biochemical basis by which SLX4IP inhibits BLM helicase, and whether its scaffolding, SUMO-recruitment, and BLM-restraining activities are mechanistically independent, remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No reconstituted SLX4IP-BLM biochemistry\", \"No structural model of SLX4IP within the SLX4 complex\", \"Functional separability of the multiple SLX4IP activities untested\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [2]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [0, 1]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 7]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [7]},\n      {\"term_id\": \"GO:0000228\", \"supporting_discovery_ids\": [0, 5, 6]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [1, 6]},\n      {\"term_id\": \"R-HSA-69306\", \"supporting_discovery_ids\": [7]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [3, 4]}\n    ],\n    \"complexes\": [\"SLX4-XPF-ERCC1 complex\", \"SMX resolvase complex\"],\n    \"partners\": [\"SLX4\", \"XPF\", \"ERCC1\", \"BLM\", \"FANCM\", \"PIAS1\", \"RAP1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"faith_supported":5,"faith_total":6,"faith_pct":83.33333333333333}}